Literature DB >> 20655381

Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin.

Satoshi Kono1, Kenichi Yoshida, Naohisa Tomosugi, Tatsuhiro Terada, Yasushi Hamaya, Shigeru Kanaoka, Hiroaki Miyajima.   

Abstract

Ceruloplasmin plays an essential role in cellular iron efflux by oxidizing ferrous iron exported from ferroportin. Ferroportin is posttranslationally regulated through internalization triggered by hepcidin binding. Aceruloplasminemia is an autosomal recessive disorder of iron homeostasis resulting from mutations in the ceruloplasmin gene. The present study investigated the biological effects of glycosylphosphatidylinositol (GPI)-linked ceruloplasmin on the hepcidin-mediated internalization of ferroportin. The prevention of hepcidin-mediated ferroportin internalization was observed in the glioma cells lines expressing endogenous ceruloplasmin as well as in the cells transfected with GPI-linked ceruloplasmin under low levels of hepcidin. A decrease in the extracellular ferrous iron by an iron chelator and incubation with purified ceruloplasmin in the culture medium prevented hepcidin-mediated ferroportin internalization, while the reconstitution of apo-ceruloplasmin was not able to prevent ferroportin internalization. The effect of ceruloplasmin on the ferroportin stability was impaired due to three distinct properties of the mutant ceruloplasmin: namely, a decreased ferroxidase activity, the mislocalization in the endoplasmic reticulum, and the failure of copper incorporation into apo-ceruloplasmin. Patients with aceruloplasminemia exhibited low serum hepcidin levels and a decreased ferroportin protein expression in the liver. The in vivo findings supported the notion that under low levels of hepcidin, mutant ceruloplasmin cannot stabilize ferroportin because of a loss-of-function in the ferroxidase activity, which has been reported to play an important role in the stability of ferroportin. The properties of mutant ceruloplasmin regarding the regulation of ferroportin may therefore provide a therapeutic strategy for aceruloplasminemia patients.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655381     DOI: 10.1016/j.bbadis.2010.07.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

Review 2.  Ferroportin-mediated iron transport: expression and regulation.

Authors:  Diane M Ward; Jerry Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-03-13

3.  sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin.

Authors:  Ryan C McCarthy; Yun-Hee Park; Daniel J Kosman
Journal:  EMBO Rep       Date:  2014-05-27       Impact factor: 8.807

4.  Is brain iron trafficking part of the physiology of the amyloid precursor protein?

Authors:  Danielle K Bailey; Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2019-10-01       Impact factor: 3.358

Review 5.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

6.  Suppressed hepcidin expression correlates with hypotransferrinemia in copper-deficient rat pups but not dams.

Authors:  Margaret Broderius; Elise Mostad; Joseph R Prohaska
Journal:  Genes Nutr       Date:  2012-03-29       Impact factor: 5.523

Review 7.  Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Mol Life Sci       Date:  2014-10-30       Impact factor: 9.261

8.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

9.  Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.

Authors:  Liangliang Zhao; Majda Hadziahmetovic; Chenguang Wang; Xueying Xu; Ying Song; H A Jinnah; Jolanta Wodzinska; Jared Iacovelli; Natalie Wolkow; Predrag Krajacic; Alyssa Cwanger Weissberger; John Connelly; Michael Spino; Michael K Lee; James Connor; Benoit Giasson; Z Leah Harris; Joshua L Dunaief
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

10.  Direct Comparison of Manganese Detoxification/Efflux Proteins and Molecular Characterization of ZnT10 Protein as a Manganese Transporter.

Authors:  Yukina Nishito; Natsuko Tsuji; Hitomi Fujishiro; Taka-Aki Takeda; Tomohiro Yamazaki; Fumie Teranishi; Fumiko Okazaki; Ayu Matsunaga; Karin Tuschl; Rajini Rao; Satoshi Kono; Hiroaki Miyajima; Hiroshi Narita; Seiichiro Himeno; Taiho Kambe
Journal:  J Biol Chem       Date:  2016-05-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.